August 3, 2021
Chugai Pharmaceutical said on August 2 that it has launched FoundationOne Liquid CDx Cancer Genomic Profile, a blood sample-based comprehensive genomic profiling (CGP) test for solid tumors, following its health coverage the previous day. The product was approved for use...read more